Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
31
2018
Are Your Food Products in Compliance With the New Prop 65 Requirements? Polsinelli PC
Jan
15
2020
New Laws in 2019 Regulating Pharmacy Benefit Managers Polsinelli PC
Mar
4
2020
What COVID-19 Means for FDA-Regulated Industry Polsinelli PC
Nov
18
2016
Weed at Work? California Prop 64 in the Workplace Polsinelli PC
Feb
27
2024
FDA 2023-24: A Look Back & A Peek Forward Polsinelli PC
May
6
2024
FDA Finalizes Rule Regulating Laboratory Developed Tests Polsinelli PC
Aug
30
2017
Federal District Court Finds Federal Law Does Not Preempt State Medical Marijuana Law’s Prohibition Against Employment Discrimination Polsinelli PC
Jul
21
2022
District of Columbia Provides Employment Protections for Off-Duty Cannabis Use Polsinelli PC
Oct
12
2022
FDA Issues Final Guidance on Clinical Decision Support Technology with Implications for Software Developers and Providers Polsinelli PC
Feb
28
2020
340B In The Spotlight – CMS 340B Acquisition Cost Survey Proposal & President’s Budget Polsinelli PC
Feb
13
2024
Revisiting Government March-In Rights Under Bayh-Dole: The FTC Weighs In Polsinelli PC
Dec
4
2018
Clarification of OSHA Rule Regarding Drug Testing and Safety Incentive Programs Polsinelli PC
Feb
12
2019
Update on Pending Legislation: Three New Bills Have the Potential to Affect Generic Pharmaceutical Companies Polsinelli PC
Feb
27
2023
DEA Announces Permanent Flexibilities for the Prescribing of Controlled Substances via Telemedicine Polsinelli PC
Apr
15
2016
Grace Period Ends Soon for California Companies with Products Containing BPA Polsinelli PC
May
11
2022
Antitrust Enforcers’ First “Listening Forum” On Merger Reform Highlights Ongoing Concerns in the Food and Agriculture Industry Polsinelli PC
Jun
16
2022
SCOTUS Sides with 340B Hospitals and Denies CMS’s Attempt to Cut Reimbursement for 340B Drugs Polsinelli PC
Feb
13
2023
Missouri Joins States Legalizing Recreational Marijuana – Cutting Through the Haze on Missouri Amendment 3 Polsinelli PC
Jan
23
2024
Select Highlights from CY 24 Medicare Physician Fee Schedule Final Rule Polsinelli PC
Mar
20
2024
Medicare Changes to Make Drug Coverage More Manageable in 2025 Polsinelli PC
Nov
6
2020
Federal Circuit Limits Venue for Hatch-Waxman Cases Polsinelli PC
Jan
23
2018
Final DOT Rule Brings Drug Testing Changes Polsinelli PC
Jan
31
2022
Pharmacy Benefit Managers Licensing and Compliance Developments Polsinelli PC
Feb
25
2022
U.S. Supreme Court Hears Rare 340B Drug Pricing Program Matter with Significant Reimbursement Implications Polsinelli PC
Feb
20
2019
Are you on the Prop 65 “Bounty Hunter” Radar? Beware, Online Sale of Wine Into California Could Cost You $2500 a Pop! Polsinelli PC
May
1
2023
SCOTUS Appears Poised To Reject Defense-Friendly Safeco Scienter Standard In FCA Cases Polsinelli PC
Jul
18
2016
Comprehensive Addiction and Recovery Act: Addressing Opioid Crisis Polsinelli PC
Nov
15
2023
Florida Proposes New Pharmacy Benefit Manager Rules Polsinelli PC
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins